Cargando…
Lactobacillus reuteri Alleviates Gastrointestinal Toxicity of Rituximab by Regulating the Proinflammatory T Cells in vivo
Rituximab (RTX) is a widely used anticancer drug with gastrointestinal side effects, such as nausea, vomiting, and diarrhea. The reason for these side effects is still poorly understood. Previous studies have reported that the intestinal microbiota is associated with the occurrence of disease and th...
Autores principales: | Zhao, Binyan, Zhou, Bailing, Dong, Chunyan, Zhang, Rui, Xie, Daoyuan, Tian, Yaomei, Yang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546249/ https://www.ncbi.nlm.nih.gov/pubmed/34712207 http://dx.doi.org/10.3389/fmicb.2021.645500 |
Ejemplares similares
-
Bacteroides fragilis participates in the therapeutic effect of methotrexate on arthritis through metabolite regulation
por: Zhou, Bailing, et al.
Publicado: (2022) -
Role of Lactobacillus reuteri in Human Health and Diseases
por: Mu, Qinghui, et al.
Publicado: (2018) -
Sustained and targeted delivery of siRNA/DP7‐C nanoparticles from injectable thermosensitive hydrogel for hepatocellular carcinoma therapy
por: Zhao, Binyan, et al.
Publicado: (2021) -
Isolation and Comparative Genomic Analysis of Reuterin-Producing Lactobacillus reuteri From the Chicken Gastrointestinal Tract
por: Greppi, Anna, et al.
Publicado: (2020) -
A Dendrimer Peptide (KK2DP7) Delivery System with Dual Functions of Lymph Node Targeting and Immune Adjuvants as a General Strategy for Cancer Immunotherapy
por: Zhang, Rui, et al.
Publicado: (2023)